The breast cancer classification is now reconsidered in the light of global gene expression analyses of human biopsies leading to six identified subtypes: luminal A and B, basal-like, claudin-low, HER2-enriched and normal breast like [10, 11]. This evidence concerns the gene ERBB2 and breast cancer.